These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38902241)

  • 1. Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection.
    Zai W; Yang M; Jiang K; Guan J; Wang H; Hu K; Huang C; Chen J; Fu W; Zhan C; Yuan Z
    Signal Transduct Target Ther; 2024 Jun; 9(1):150. PubMed ID: 38902241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of PLK1-targeting siRNA delivered by lipid nanoparticles in HBV-infected hepatocytes.
    Foca A; Dhillon A; Lahlali T; Lucifora J; Salvetti A; Rivoire M; Lee A; Durantel D
    Antivir Ther; 2020; 25(3):151-162. PubMed ID: 32496211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HBV efficacy of combined siRNAs targeting viral gene and heat shock cognate 70.
    Bian Z; Xiao A; Cao M; Liu M; Liu S; Jiao Y; Yan W; Qi Z; Zheng Z
    Virol J; 2012 Nov; 9():275. PubMed ID: 23158906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
    Michler T; Kosinska AD; Festag J; Bunse T; Su J; Ringelhan M; Imhof H; Grimm D; Steiger K; Mogler C; Heikenwalder M; Michel ML; Guzman CA; Milstein S; Sepp-Lorenzino L; Knolle P; Protzer U
    Gastroenterology; 2020 May; 158(6):1762-1775.e9. PubMed ID: 32001321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Single Dose of Anti-HBsAg Antibody-Encoding mRNA-LNPs Suppressed HBsAg Expression: a Potential Cure of Chronic Hepatitis B Virus Infection.
    Chen B; Chen Y; Li J; Wang C; Song W; Wen Y; Lin J; Wu Y; Ying T
    mBio; 2022 Aug; 13(4):e0161222. PubMed ID: 35862767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference as a novel treatment strategy for chronic hepatitis B infection.
    Hui RW; Mak LY; Seto WK; Yuen MF
    Clin Mol Hepatol; 2022 Jul; 28(3):408-424. PubMed ID: 35172540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient delivery of HBV NLS siRNAs into HepG2.2.15 cells for HBV inhibition through novel recombinant preS1‑tP proteins.
    Zeng Y; Li Z; Shang J; Kang Y
    Int J Mol Med; 2018 Aug; 42(2):1181-1189. PubMed ID: 29786106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel pH-sensitive multifunctional envelope-type nanodevice for siRNA-based treatments for chronic HBV infection.
    Yamamoto N; Sato Y; Munakata T; Kakuni M; Tateno C; Sanada T; Hirata Y; Murakami S; Tanaka Y; Chayama K; Hatakeyama H; Hyodo M; Harashima H; Kohara M
    J Hepatol; 2016 Mar; 64(3):547-55. PubMed ID: 26505121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs.
    Morrissey DV; Lockridge JA; Shaw L; Blanchard K; Jensen K; Breen W; Hartsough K; Machemer L; Radka S; Jadhav V; Vaish N; Zinnen S; Vargeese C; Bowman K; Shaffer CS; Jeffs LB; Judge A; MacLachlan I; Polisky B
    Nat Biotechnol; 2005 Aug; 23(8):1002-7. PubMed ID: 16041363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted in vivo delivery of siRNA and an endosome-releasing agent to hepatocytes.
    Sebestyén MG; Wong SC; Trubetskoy V; Lewis DL; Wooddell CI
    Methods Mol Biol; 2015; 1218():163-86. PubMed ID: 25319651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
    Shin D; Kim SI; Kim M; Park M
    Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection.
    Wooddell CI; Rozema DB; Hossbach M; John M; Hamilton HL; Chu Q; Hegge JO; Klein JJ; Wakefield DH; Oropeza CE; Deckert J; Roehl I; Jahn-Hofmann K; Hadwiger P; Vornlocher HP; McLachlan A; Lewis DL
    Mol Ther; 2013 May; 21(5):973-85. PubMed ID: 23439496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-based meta-analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B-infected mice.
    Sandra L; T'jollyn H; Vermeulen A; Ackaert O; Perez-Ruixo JJ
    CPT Pharmacometrics Syst Pharmacol; 2024 May; 13(5):729-742. PubMed ID: 38522000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
    Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
    Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanoparticle-mediated delivery of IL-21-encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence.
    Shen Z; Zhang S; Jiang Q; Liu N; Li F; Gao Z; Pan S; Hao W; Deng Q; Liu J; Zhang J; Xie Y
    J Med Virol; 2023 Sep; 95(9):e29062. PubMed ID: 37665238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice.
    Ying RS; Zhu C; Fan XG; Li N; Tian XF; Liu HB; Zhang BX
    Antiviral Res; 2007 Jan; 73(1):24-30. PubMed ID: 16844238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA.
    Deng L; Li G; Xi L; Yin A; Gao Y; You W; Wang X; Sun B
    BMC Gastroenterol; 2009 Oct; 9():73. PubMed ID: 19804649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B.
    Huang Y; Zheng S; Guo Z; de Mollerat du Jeu X; Liang XJ; Yang Z; Zhang HY; Gao S; Liang Z
    Signal Transduct Target Ther; 2022 Feb; 7(1):38. PubMed ID: 35145057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.